#Cannabis/ Therapeutic #Stock News-American Premium
Water Corp (OTC: $HIPH) Expanded Vanexxe #VaricoseVein Treatment Product
Distribution in Australia with Nutra Pty. Ltd
The
global varicose vein treatment market was valued at $376.64 million in 2017,
and is expected to reach $589.06 million by 2025, growing at a CAGR of 5.7%
from 2018 to 2025.- Allied Market Research
PLAYA VISTA, CA, January 31, 2020 (Investorideas.com Newswire) American Premium Water Corporation (OTC: HIPH) recently reported that Canyon Create Corp, the manufacturer of
Vanexxe has entered into a Letter of Intent (LOI) with Nutra
Pty. Ltd. (Nutra), an Australian corporation with
extensive reach in distribution of personal products, to engage in the licensed
production and sale of Vanexxe throughout Australia and Southeast Asia. The
Company has an equitable interest in Canyon Create Corp.
Read this news featuring HIPH in full at https://www.investorideas.com/news/2020/cannabis/01311OTCHIPH-Vanexxe.asp
American Premium Water Corporation CEO Ryan
Fishoff commented, “This is an exciting day for Vanexxe! Not only is this
ground breaking product expanding to Australia, its also being evaluated by the
TGA to be classified for therapeutic use. If approval is given, it will greatly
expand the number of channels that can sell the product. It will also offer
further validation of the product and its efficacy. The LOI with Nutra Pty
falls in line with our focus on international expansion, and has been in the
works for some time, as the Company stated back in July that it was in discussions with distributors
across the Pacific Rim. Establishing a foothold in the Pacific has been a
stated goal of the Company’s. As we move into 2020, we will continue to focus
on expanding into this region. I look forward to updating shareholders when the
Nutra Pty LOI is completed and the Company’s other activities in the area.”
The Therapeutic Goods Administration (TGA) is
the regulatory body for therapeutic goods (including medicines, medical
devices, gene technology, and blood products) in Australia. The LOI with Nutra
stipulates that they would be responsible for the manufacturing and
distribution of Vanexxe in Australia and surrounding regions in Southeast Asia.
Nutra will also take the lead in shepherding the product through the approval
process of the TGA. Australia is one of the world’s largest economies, having
the 14th largest GDP globally.
Canyon Create Founder and President, Campbell
McAuley, said: “This is the most encouraging news to date that we will be able
to have our products marketed extensively in Australia and in the Southeast
Asian region based on this anticipated approval by the TGA. We are confident
that Nutra is an excellent manufacturing partner that will be able to meet our
expectations, resulting in what we project will be the production and sale of
hundreds of thousands of units of Vanexxe, as well as our other skin care
topical brands.”
LALPINA CBD water can be purchased online at
visiting https://www.singleseed.com/product/lalpina-cbd-water-6-pack/
LYNKS Pet CBD Water can be purchased online:
Vanexxe can be purchased on Amazon here
Vanexxe Varicose Vein Treatment - vein
support for varicose veins and to help reduce the appearance of varicose veins
Price: $49.99 ($25.00 / Fl
Oz)
·
VISIBLE RESULTS IN 45 minutes - 2
hours THANKS TO THESE ALL NATURAL INGREDIENTS Ginko Biloba, Activated B
Vitamins, Antioxidants, and Peptides
·
We pride ourselves on lab-tested,
pesticide, metal, toxin, and cruelty free products. All of our product
ingredients are ethically formulated in FDA approved laboratories and CGMP
compliant facilities. We insure performance-based ethical products with the collaboration
of industry leading dermatologists, clinicians, aroma therapists, skincare
specialists and beauty experts.
The Company’s research report was recently
updated by Ludlow Research with a short-term price target of $0.03. To read
full report, risks, and disclosures, click here
About American Premium Water Corp.
American Premium Water (HIPH) is a diversified
luxury consumer products company focused on businesses in the health and beauty
and biotech sectors. The company is focused on harnessing the powers of Nano
technologies paired without cannabidiol (CBD) to treat health disorders and
enhance quality of life. The company’s portfolio includes the LALPINA Hydro and
LALPINA CBD brands (www.lalpinahydrocbd.com),
Gents (www.gentsco.com), Vanexxe (www.vanexxe.com) and plant + body
essentials (www.plantbodyessentials.com).
American Premium Water strives in providing
only the highest quality CBD sources for its products, with quality control
being one of our first and foremost focuses. The Company aims for this standard
not only for compliance reasons, but also to provide our customers the highest
quality product possible.
About Canyon Create Corp.
Canyon Create Corp., a Nevada Corporation, is
the developer of Vanexxe (www.vanexxe.com), a patented cosmetic cream that uses
a proprietary formulation to eliminate the appearance of varicose veins. The product
works by simultaneously bringing
heightened blood flow to the bulged vein valve, allowing it to pull away
from the dermis and return to a more normal condition, and increases the
elasticity in the upper skin layers to provide healthier skin, assisting in
moving the vein back to a non-visible location.
Safe Harbor Notice
Certain statements contained herein are
“forward-looking statements” (as defined in the Private Securities Litigation
Reform Act of 1995). American Premium Water Corporation cautions that
statements made in this news release constitute forward-looking statements and
makes no guarantee of future performance. Forward-looking statements are based
on estimates and opinions of management at the time statements are made. These
statements may address issues that involve significant risks, uncertainties,
estimates and assumptions made by management. Actual results could differ
materially from current projections or implied results. American Premium Water
Corporation undertakes no obligation to revise these statements following the
date of this news release. Additional
details of the Company's business can be found in its public disclosures as a
reporting issuer under the Securities Exchange Act of 1934 filed with the
Securities and Exchange Commission's ("SEC") EDGAR database.
This press release is issued on behalf of the
Board of Directors of American Premium Water Corporation.
Investor Relations
888-983-0054
The global varicose vein treatment market was valued at $376.64
million in 2017, and is expected to reach $589.06 million by 2025, growing at a
CAGR of 5.7% from 2018 to 2025.- Allied Market Research
News -Disclaimer/Disclosure: Investorideas.com
is a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. Disclosure : this news release HIPH is a paid for news release on
Investorideas.com More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Please
read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
About Investorideas.com
Sign up for free stock
news alerts at Investorideas.com
No comments:
Post a Comment